<DOC>
	<DOCNO>NCT01483443</DOCNO>
	<brief_summary>This prospective phase III trial define role oophorectomy metastatic colorectal cancer patient ovarian metastasis .</brief_summary>
	<brief_title>Oophorectomy Followed Chemotherapy Versus Chemotherapy Alone Colorectal Cancer Patients</brief_title>
	<detailed_description>A recent study demonstrate colorectal cancer ovarian metastases less responsive chemotherapy compare extraovarian metastasis . The survival impact oophorectomy define yet clinical setting . The incidence microscopic ovarian metastasis report approximately 10 % . Therefore , investigator propose prospective study oophorectomy follow standard chemotherapy versus standard chemotherapy alone determine whether oophorectomy increase survival .</detailed_description>
	<criteria>1. age â‰¥ 18 2. histologically confirm adenocarcinoma colon 3. documented ovarian metastasis CT MRI PETCT 4. advance ( stage IV ) , metastatic , recurrent 5 . ECOG performance status 0~2 6. adequate marrow , hepatic , renal cardiac function 7. prior surgical treatment ovary 8. provision sign write informed consent 1. patient refuse oophorectomy 2. medical condition surgery tolerate Any waiver inclusion exclusion criterion must approve investigator caseby case basis prior enrol subject . This must document investigator . No subject allow enroll study .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>oophrectomy</keyword>
	<keyword>survival</keyword>
</DOC>